Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Male Infertility
NCT03030196Phase 2Completed
- Start
- Jan 2017
- Primary completion
- Jan 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in male infertility. Started Jan 2017; status: completed.
02
Drugs
denosumab
03
Conditions
male infertility
Beyond the preview
Go deeper on NCT03030196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03030196.